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Abstract
In vitro cell lines from DRG neurons aid drug discovery because they can be used for early
stage, high-throughput screens for drugs targeting pain pathways, with minimal depen-
dence on animals. We have established a conditionally immortal DRG cell line from the
Immortomouse. Using immunocytochemistry, RT-PCR and calcium microfluorimetry, we
demonstrate that the cell line MED17.11 expresses markers of cells committed to the sen-
sory neuron lineage. Within a few hours under differentiating conditions, MED17.11 cells
extend processes and following seven days of differentiation, express markers of more ma-
ture DRG neurons, such as NaV1.7 and Piezo2. However, at least at this time-point, the no-
ciceptive marker NaV1.8 is not expressed, but the cells respond to compounds known to
excite nociceptors, including the TRPV1 agonist capsaicin, the purinergic receptor agonist
ATP and the voltage gated sodium channel agonist, veratridine. Robust calcium transients
are observed in the presence of the inflammatory mediators bradykinin, histamine and nor-
epinephrine. MED17.11 cells have the potential to replace or reduce the use of primary
DRG culture in sensory, pain and developmental research by providing a simple model to
study acute nociception, neurite outgrowth and the developmental specification of DRG
neurons.
Introduction
The cell bodies of sensory neurons of the peripheral nervous system reside in the cranial and
dorsal root ganglia (DRG). Sensory neuron function is altered in response to the endogenous
release of inflammatory mediators in myriad pathological conditions [1]. DRG neurons in pri-
mary culture have been used to study the molecular mechanisms of acute nociception and pe-
ripheral sensitisation as well as to screen for drugs targeting these pathways. The drawbacks of
primary culture include limited material requiring large numbers of animals to be sacrificed, la-
bour intensive isolation procedures, poor transfection efficiencies, heterogeneity of cytochemi-
cal phenotypes and the presence of non-neuronal cells that confound “omic” studies. Several
DRG cell lines have been generated, including the rat DRG/mouse neuroblastoma hybrid cell
lines [2,3] and a rat embryonic DRG cell line [4]. But given the large number of DRG neuron
subpopulations, more cell lines are required to represent the diversity of phenotypes. Moreover
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since the development of transgenic and gene knockout technology, there has been an in-
creased reliance on murine models to study the mechanisms of acute and pathological pain
and peripheral nervous system development. To date, no murine DRG cell lines exist to com-
plement such studies. Recently, cells with nociceptive properties were derived from human plu-
ripotent stem cells (hPSCs) using combined small molecule inhibition [5,6]. However, the
reported protocols involve painstaking maintenance and manipulation of stem cells and re-
quire up to seven weeks for the emergence of some nociceptive markers. For these reasons, we
set out to create mouse DRG cell lines with nociceptive properties and to develop an efficient
differentiation protocol. We used the Immortomouse [7] to clone immortalised sensory neu-
ron progenitors. The Immortomouse expresses a thermolabile simian virus 40 large T antigen
tsA58. The transgene is under the control of the Major Histocompatibility Complex (MHC)
H-2Kb Class I promoter, which is basally active in many tissues and can be further induced by
interferon. At 33°C, the large T antigen tsA58 is stable, but at 39°C the protein is rendered
non-functional. The Immortomouse has been used to create many conditional cell lines from
mitotic cells. To increase the likelihood of isolating neurons of the nociceptive lineage, we iso-
lated several lines from embryonic day E12.5 DRG, a developmental stage when proprioceptive
and low threshold mechanoreceptive-lineage neurons have terminally differentiated but noci-
ceptive lineage neurons are still dividing. Here we present the derivation and characterisation
of the Mouse Embryonic DRG (MED) cell line, MED17.11. These cells express markers of
committed sensory neuron progenitors. However, when cultured in our differentiation medi-
um, they express markers of maturing DRG neurons including numerous ion channels. We
also observed functional responses to noxious compounds and inflammatory mediators.
Therefore the MED17.11 cells may provide a simple model to study both acute nociception, de-
velopmental specification of DRG neurons and potentially the mechanisms of peripheral
sensitisation.
Materials and Methods
Animals and DRG culture
A small Immortomouse mouse colony was maintained by the university of Sheffield Biological
service unit. Breeding and maintenance of the mouse colony was carried out under Home Of-
fice Project License PPL 40/3430. Mice of all ages were sacrificed using a humane method as
listed in Schedule 1 of the Animal (Scientific procedure) Act 1986. E12.5 embryos from the
H2kbtsA58 Immortomouse were killed by immersion in ice-cold PBS followed by decapitation.
DRG from all vertebral levels were collected into PBS on ice and tail tips were harvested for
genotyping for the presence of the temperature-sensitive SV40 large T antigen (TSA58-sense
5’-TGCCAGGTGGGTTAAAGGAGCATGA-3’ and TSA58-antisense 5’-AGCCAAGCAACT
CCAGCCATCCA-3’). The DRG were digested for 40 minutes in a mixture of 0.6 mg/ml colla-
genase type IX (Sigma) and 1 mg/ml Dispase II (Gibco) in enzyme incubation solution [8] at
37°C in 5% CO2 and 95% air. Following trituration, the DRG were resuspended in medium
permissive for T antigen expression. This comprised a basal medium of DMEM/F12 with stable
glutamine, penicillin and streptomycin and 10% FBS (all PAA), supplemented with interferon
gamma (100 units/ml during initial establishment of DRG cell lines and reduced later to 50
units/ml), chick embryonic extract at 0.5% (Sera Labs) was added to augment the proliferation
rate. The cells were cultured at 33°C for a few passages before cloning.
Establishment of DRG Cell Lines
Individual clones were isolated by cloning rings. We observed that cloning by limited dilution
in multi-well plates lead to differentiation and death of cells. Primary clones were subjected to
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an initial screen to select for βIII-tubulin (Tuj1) immunoreactivity. These primary clones were
subcloned until homogeneity of shape and Tuj1 expression was observed. The cell lines were
routinely cultured in permissive medium (proliferating conditions) and passaged weekly. We
have selected for clones with robust growth over more than 100 passages.
Differentiation in Non-Permissive Conditions
Before all experiments, the cells were plated onto polyornithine-coated glass coverslips or tissue
culture-treated plastic and transferred to non-permissive medium for T-antigen expression
overnight (medium as above, but without interferon gamma and chick embryonic extract).
The large T antigen protein is rendered non-functional at 39° C [7]. However, this temperature
is close to the thermal activation threshold of the heat and capsaicin receptor, TRPV1 (~42°C)
which is expressed early in developing DRG [9], so to avoid activation of the ion channel, the
cells were maintained at 37°C.
Immunocytochemistry
Cells were washed in ice-cold phosphate buffered saline (PBS) and fixed in 4% paraformalde-
hyde for 10 minutes. Paraformaldehyde autofluorescence was quenched by incubation with 50
mM ammonium chloride for 20 minutes. The cells were permeabilised for 15 minutes in PBS
with 0.1% TritonX-100, washed and placed in blocking solution for one hour at room tempera-
ture prior to overnight incubation with primary antibodies at 4°C. Following, three washing
steps in PBS, the cells were incubated with DAPI (1:5000) and Alexa Fluor anti-mouse or anti-
rabbit secondary antibodies for two hours at room temperature (1:2000 each, Life Technolo-
gies). After another three washing steps, coverslips were mounted on slides using Prolong Gold
(Life Technologies). Antibodies were verified in adult primary DRG in culture. We used mono-
clonal antibodies for Tuj1 (1:1000, R &D), CNPase (1:250, Abcam) and GFAP (1:250, Sigma).
The polyclonal antibodies used were Isl1 (1:250, Abcam), FOX3 (NeuN, 1:250, Millipore),
SOX10 (1:250, Abcam), Advillin (1:500, Abcam), TrkA, TrkB and TrkC (1:500, Alomone),
Nav1.3 (1:500, Alomone), and SV40 (1:250, Santa Cruz).
RT-PCR
RNA isolation was performed using TRI-reagent (Sigma) and Direct-zol RNA mini-prep
(Zymo Research) according to the manufacturers’ instructions. Primers were designed to flank
exon junctions and across two exons using NCBI Primer BLAST (Table 1). Reverse transcrip-
tion (2000 ng input RNA) was performed using High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems) with random hexamers. cDNA was amplified by PCR using Go Taq
polymerase with 5x Green buffer (Promega). The synthesised cDNA (50 ng of calculated from
original RNA) was used as a template for RT-PCR, using primers summarised in Table 1. Fol-
lowing initial denaturation at 95°C for 10 minutes; the cDNA was amplified for 35 cycles using
the following parameters: 95°C for 45 seconds; 57°C for 30 seconds, 72°C for 30 s. A final ex-
tension was performed at 72°C for 10 minutes. Primers were validated with cDNA synthesised
from adult and E13.5 DRG mRNA.
Calcium Imaging
Cells were loaded with 2 μM Fura2-AM (Molecular Probes) for 30 minutes and allowed to re-
cover in standard extracellular solution for a further 30 minutes before experiments. All re-
cordings were performed at room temperature. The cells were superfused with standard
extracellular solution for at least 5 minutes before beginning recordings. Ratiometric
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measurements of intracellular calcium [Ca2+]i were made using a Cairn Dual OptoLED (exci-
tation wavelengths: 350 and 380 nm) with a Hamamatsu C4742-95 camera and Simple PCI 6
software (Hamamatsu). Background subtraction and ratio calculations (350/380 nm) were per-
formed within the software. Standard extracellular solution contained the following (mM):
NaCl (140); KCl (4); CaCl2 (2); HEPES (10); NaOH (4.54) and glucose (5). For high potassium
extracellular solution, the concentration of KCl was increased to 40 mM and NaCl was reduced
to 104 mM. Both solutions were adjusted to pH 7.4 at room temperature using NaOH. We test-
ed three fields of cells for each compound. To avoid desensitisation mechanisms, only one
stimulus was applied per coverslip, unless the cells failed to respond, in which case another
drug was tested on the same coverslip.
Compounds
All drugs were applied in standard extracellular solution from the following stock solutions:
capsaicin (10 mM in ethanol), veratridine (50mM in ethanol), WS-12 (10 mM in DMSO),
ATP (2mM in H2O), bradykinin (0.5 mM in H2O), serotonin (5mM in H2O), histamine (1mM
in H20), norepinephrine (0.5 mM in HCl). Solvents were added to the control standard extra-
cellular solution at the same final concentration as the drug solution.
Data Processing and Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6 software and SigmaPlot version
12.0. For the calcium imaging data, cells that responded with a rise in fluorescence ΔF/F0 =
0.1 were considered to be responders.
Table 1. Primer Sequences 5'-3'.
Target Sense Primer Antisense Primer Accession Number
SOX10 TGCTGCTATTCAGGCTCACTACAA CAGGTATTGGTCCAGCTCAGTCAC NM_011437.1
P75 GGGCACATACTCAGATGAAGCCAA CAGCAGCCAAGATGGAGCAATAGA NM_033217.3
FOXS1 GGCATCTACCGCTACATCATGGG ACAGTCTGCCAGTTGTGGTCTTG NM_010226.2
Advillin GGGTCAGTTCCAGGAAGACAGC GAAGTAGCCACGGAAGGTGTCG NM_009635
Brn3A CCACTTACTGAGGAGGGTGTGAGA TGTGACTCAACATTTATCCCCGGT NM_011143.4
cRET AGGAAATGTACCGTCTGATGCTGC TACAGAGAGTTGGGATGGTGCAGA NM_001080780.1
TrkA GGGAGTTGAGAAGCCTAACCATCG CAGAGTCATTGGGCATCTGGATCT NM_001033124.1
TrkB CAATGAGAGCAGCAAGAACATGCC GATAGTTGGCGCAAAATGCACAGT NM_001025074.2
TrkC TTACTACAGGGTGGGAGGACACAC AAGAATGTCCAGGTAGATCGGGGT NM_008746.5
Runx1 GGTAGCGAGATTCAACGACCTCAG ATCCTGCATCTGACTTTGAGGCTG NM_001111021.2
Runx3 AGCCAACCAAGTGGGTCTGAAC AGCACGGAGCAGAGGAAGTTG NM_019732.2
TRPV1 ACATCTGGAAGCTGCAGCGAG TTGCGTCCCTCAGAAGGGGA NM_001001445.1
TRPV2 ACTGGGCCAGCTGTGGTACT GCCTCCCGGCTCAAGCTTAC NM_011706.2
TRPA1 CCTGCTTCACAGAGCCTCGTTATT GCCTACAGGCATAATGGAGAGGTG NM_177781.4
Piezo1 TCATCATCTCTAAGAATATGCTGTCGCTC CAATCTGGCGATGGAAGTTGATG NM_001037298.1
Piezo2 CTCTGTGTCCTGCTGGCAATCTTCA CCTCTCTGCCGTGTTCTGATTGGAG NM_001039485.4
CGRP CGCTCACCAGGAAGGCATCAT GTTGTCCTTCACCACACCTCCTG NM_001033954.3
Nav1.9 ATCCCAAGGCCCCTGAACAAA GTGTGGGCGGGAAGACGTTG NM_011887.3
ATTCCAGAGGGAAAGATGAGCAGC TCAAAGACCTGGCTTGTGACCAAA
Nav1.8 AACAATACTGGCCACTTCTTCTGGG CATGAAGATGTCCTGGCCCCTTAT NM_009134.3
Nav1.7 AGCAGGAAGAAGCCGAGGTAGTAT AATGCTGAGTGGTGACTGGTTGG NM_018852.2
TTCCGAGGCCAGGGAACAAAT GCGAATGACTCGGAACAGGGT
doi:10.1371/journal.pone.0128670.t001
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Cell surface area measurements were performed in Image J. A free-hand region of interest
was drawn around the perimeter of the soma. The cell diameters were estimated from the area,
which was assumed to be equal to πr2.
Transient Transfection
Transient transfection with pmaxGreenFP was performed using Lipofectamine LTX with the
Plus reagent. Cells were seeded at density of 12500/cm2 for transfection the following day.
For each cm2 the following was added in antibiotic free medium: 0.25 μg of DNA, 0.25 μl of
plus reagent and 0.75 μl lipofectamine LTX were used. Transfection was allowed to proceed
overnight.
Results
Initial screen of immortalised Tuj1 positive clones
We selected dividing cells for cloning from E12.5 cultures on the basis of immunoreactivity for
the neuron-specific marker Tuj1 and then selected 28 clones based on robustness of proliferation
and uniformity of Tuj1 expression. Using RT-PCR and immunocytochemistry we screened these
28 clones for markers of neural crest cells, glia and post-mitotic sensory neurons, both in prolifer-
ating conditions and following differentiating conditions (data not shown). MED17.11 cells were
identified as having an advanced sensory neuron-like profile coupled with a strong proliferation
capacity. This clone was chosen for further detailed characterisation.
Proliferating MED17.11 cells express neuronal markers and can be
transfected
When maintained in proliferating conditions, the cells adopted a flattened morphology (Fig 1)
and were immunopositive for the generic neuronal markers Tuj1 and FOX3 (NeuN, Fig 1).
MED17.11 cells were also immunopositive for the LIM homeodomain transcription factor Isl1
(Fig 1), which plays a role in sensory neuron survival and maturation, in particular for nocicep-
tors [10]. Importantly, MED17.11 was negative for the glial markers GFAP, SOX10 and
CNPase (data not shown).
Screens involving gene over-expression or knockdowns in primary DRG neurons in culture
are difficult, owing to the challenge of obtaining high quantities of purified neurons, poor
transfection efficiencies, particularly with standard lipid based transfection reagents which can
cause a loss of cell viability. As proof of principle we have demonstrated that MED17.11 cells
can be transfected using a lipofection-based reagent (Fig 1, GFP).
Differentiated cells rapidly adopt a neuronal morphology and express the
DRG neuron marker Advillin
The protocol for differentiation is represented in Fig 2A. Our differentiation medium con-
tained bFGF (10 ng/ml, R&D Systems), di-butryl cAMP (0.5mM, Sigma), forskolin (25 μM,
Cell Signalling Technology) [11] and rock inhibitor Y-27632 (5 μg/ml, Chemdea), which pro-
motes neurite outgrowth in embryonic DRG [12] and induces neural crest cell differentiation
[13]. Growth factors NGF (100 ng/ml) and GDNF (20 ng/ml, both R&D) were also added to
the differentiating medium, the former being required for nociceptor survival and both playing
a role in phenotype specification. Within hours of switching to the differentiation medium, the
majority of cells displayed a bipolar morphology typical of immature DRG neurons [14]. Fig
2B and 2C are bright-field images after three days in differentiating medium (day 5 of the dif-
ferentiation protocol, Fig 2A). The majority of cells had a phase-bright rounded soma with two
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processes which extended in length and branched extensively in culture. We found that mor-
phological differentiation was strongly dependent on cell density and was optimal when the
cells were plated at 5000-15000/cm2. At higher densities a smaller percentage of cells showed
visible differentiation and at lower densities the survival rates were poor.
MED17.11 cells displayed some heterogeneity in terms of cell size. Fig 2D shows the fre-
quency distribution of soma diameters measured on day 5 of the differentiation protocol. Cell
body diameters ranged from 8 to 32 μm, but 77.8% of MED17.11 cells were between 14 and
20 μm, with a mean diameter of 18.2 ± 0.2 μm (n>200 cells). The cell diameters showed a
small but significant decrease over days post-differentiation (Fig 2E). This is attributable to the
loss of a small population of larger diameter cells over this period. The soma size is equivalent
to small diameter adult neurons, but larger than reported in mouse at E15.5 [15] where TrkA-
positive (nociceptive) and RET positive (early RET expressing, mechanoreceptive, population)
neurons had a mean diameter of 10.1 and 15.5 μm respectively (reported as surface
area = 80.6 ± 1.8 μm2 and 187.8 ± 7.6 μm2; diameter calculated assuming area = πr2).
MED17.11 cells were uniformly immunoreactive for the sensory neuron marker Advillin (Fig
2F) which is selectively expressed in rat DRG and superior cervical ganglia [16] and has even
more restrictive DRG expression in mouse [17].
MED17.11 cells are committed to the sensory neuron lineage and
mature when differentiated
To understand whether morphological differentiation by our medium was coupled to cyto-
chemical maturation, we screened the cells for markers of sensory neurons and neural crest
Fig 1. MED17.11 express the early neuronal markers FOX3 (NeuN), Isl1 and Tuj1, and can be
transfected with GFP. Immunolabelling of MED17.11 cells cultured in permissive conditions for large T
antigen expression. GFP transgene expression in MED17.11. Scale bar is 100 μm.
doi:10.1371/journal.pone.0128670.g001
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cells using RT-PCR in proliferating and differentiating conditions (7 days, which is day 9 of the
differentiation protocol, Fig 2A). We included some markers that are expressed in modality-
specific subpopulations of DRG and whose expression pattern has been described in embryon-
ic DRG. However, the primary focus was on markers of nociceptive neurons. The mRNA phe-
notype is summarised in Fig 3 and suggests that the undifferentiated cells are already
Fig 2. Morphological differentiation of MED17.11. A, Protocol for differentiation of MED17.11 cells. Bright-
field images (B and C) of MED17.11, 3 days after the addition of differentiation medium. B, Lowmagnification
images illustrate the high efficiency of morphological differentiation using the protocol shown in A. The small
black arrow points to the rarer large diameter neurons. C, Higher power images showing the typical
morphology of MED17.11 cells. The large black arrow points to an example of process branching. D,
Frequency distribution of cell soma diameters (left) demonstrates the diversity of cell sizes following
differentiation. E, Histogram showing change in soma diameter post differentiation (right) * = p<0.05, ** =
p<0.001 (mean + S.E.M; Student’s unpaired two tailed t test). F, Immunofluorescence images of MED17.11,
3 days after the addition of differentiation medium. Both soma and processes of MED17.11 cells label with the
neuronal marker, Tuj1, and the sensory neuron marker, Advillin. All scale bars are 50 μm.
doi:10.1371/journal.pone.0128670.g002
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committed to the sensory neuron lineage, but mature when cultured in our differentiation me-
dium as described below.
In agreement with immunocytochemical analysis, in proliferating conditions, we did not de-
tect mRNA for SOX10, a marker of multipotent neural crest cells whose expression is subse-
quently maintained only in glial cells [18]. Importantly, we detected expression of FOXS1,
which is restricted to sensory neuron committed cells and is not expressed in the sympathetic
chain in E12.5 mice [15]. In agreement with immunocytochemical analysis, we also detected
mRNA for Advillin in both proliferating and differentiated cells. Taken together this suggests
that the phenotype of MED17.11 cells correlates well with committed sensory neuron
progenitors.
Within peripheral sensory neurons, RUNX1 is selectively expressed in developing nocicep-
tive lineage neurons and maintained in the non-peptidergic nociceptor population postnatally
[19] [20]. After just one day in differentiating conditions MED17.11 cells expressed this tran-
scription factor (Fig 3). TrkA is initially found in all nociceptors/thermoreceptors (but not
large diameter neurons), but postnatally, it is down-regulated in half of the population. These
neurons start to express the GDNF receptor, cRET, do not synthesise peptides such as CGRP
and substance P and label with the plant isolectin, IB4 [15]. Differentiated MED17.11 express-
ed mRNA for cRET; interestingly, we also detected mRNA for CGRP, a marker of peptidergic
nociceptors. This suggests that MED cells are capable of differentiating into different subpopu-
lations of DRG neurons (note that the differentiation medium contains both NGF and GDNF).
We also detected mRNA for TRPV2, which is expressed in post-mitotic DRG neurons and de-
veloping motor neurons from E11, but not in other spinal cord neurons [20]. Of note, we also
Fig 3. mRNA and Immunocytochemical profiles of MED17.11. Left, mRNA analysis of proliferating and
differentiated MED17.11 cells: “Undiff” refers to cells grown in proliferating conditions (see methods). “Diff” refers
to cells grown in differentiating conditions for 7 days (day 9 of differentiation protocol in Fig 2, also see methods).
A “+” indicates that the cell line was positive and a “-” indicates that the cell was negative for the corresponding
marker. A”?” indicates that themarker was not tested in the given condition A. The “*” beside Runx1 indicates
that this nociceptor marker was also tested after one day in differentiation conditions and was positive. LTM = low
threshold mechanoreceptor, VGSC = voltage gated sodium channel. Right, immunocytochemical analysis of
MED17.11 cells differentiated for 7 days. The cells showed immunoreactivity for the modality specific markers
TrkA and TrkC (top) and the embryonic VGSC, Nav1.3 (bottom left). Live MED17.11 cells also strongly labelled
with IB4 (bottom right). Scale bar is 50 μm.
doi:10.1371/journal.pone.0128670.g003
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detected mRNA for the mechanosensor proteins, Piezo1 and Piezo2. Both are expressed in
DRG, with Piezo 2 being highly enriched in adult DRG [21] but their expression profiles have
not been reported in embryonic DRG.
To determine whether the cells expressed markers of proprioceptor/mechanoreceptor line-
age neurons, we looked for expression of receptor tyrosine kinases TrkB and TrkC as well as
the runt domain transcription factor Runx3. When differentiated MED17.11 expressed TrkC
and Runx3 (Fig 3).
Voltage gated sodium channels (VGSCs) confer electrical excitability to adult sensory neu-
rons with NaV1.7, NaV1.8, and NaV1.9 being important molecular substrates underlying the
excitability of nociceptors in DRG neurons. Following differentiation, we could not detect
mRNA for Nav1.8 at this time-point (7 days in differentiating conditions), however, the cells
expressed mRNA for VGSC NaV1.7 whose expression in sensory neurons is required for both
acute and inflammatory pain [22,23] and the TTX resistant NaV1.9, which is enriched in non-
peptidergic nociceptors [24,25].
To determine whether mRNA expression analysis reflected actual protein translation and to
confirm the reproducibility of our protocol, we screened cells in differentiating conditions for 7
days using antibodies against trkA and trkC (Fig 3B). In agreement with mRNA analysis, both
cells were immunopositive for the two receptor tyrosine kinases. While all cells were immuno-
positive, the level of intensity was heterogeneous, suggesting that each receptor was enriched in
certain cells. Live MED17.11 cells labelled strongly with isolectin B4 (IB4, Fig 3) which, as stat-
ed above, predominantly labels small diameter, non-peptidergic neurons.
Although mRNA and immunocytochemical evidence suggests that MED17.11 cells mature
in our differentiation medium, it is unclear whether they still retain properties of embryonic
neurons. While the VGSC NaV1.3 is not expressed in healthy adult DRG neurons, it is highly
expressed in the developing DRG [26], making it a useful indicator for the degree of neuronal
maturation. Indeed, all MED17.11 cells were immunoreactive for Nav1.3 suggesting cells dif-
ferentiated for 7 days are still embryonic in nature.
MED17.11 responds to noxious compounds and the voltage-gated
sodium channel agonist veratridine
To investigate whether MED17.11 cells express functional receptors found specifically in noci-
ceptors, we used Fura-2 AM calcium microfluorimetry to examine the responses of cells in pro-
liferating and differentiating (3–6 days) conditions to compounds known to excite sensory
neurons (Fig 4). Representative traces of responses are shown in Fig 4A.
In agreement with RT-PCR data, differentiated MED17.11 cells were sensitive to the
TRPV1 agonist capsaicin (10 μM), a canonical nociceptor marker (Fig 4A upper). 71% of dif-
ferentiated cells were responsive, compared with proliferating conditions when none re-
sponded to capsaicin. The mean capsaicin response magnitude was ΔF/F0: 0.43 ± 0.05 (Fig 4B).
KCl depolarisation of DRG neurons elicits calcium transients by activating voltage gated
calcium channels, which are selectively expressed in neuronal cells of the DRG. In the develop-
ing DRG, capsaicin responses are only observed in neurons capable of being depolarised by
KCl [9], therefore we expected that a large percentage of MED17.11 cells could be depolarised
by KCl. Indeed, more than 90% of MED17.11 cells responded to KCl, with a mean response
amplitude of ΔF/F0: 0.38 ± 0.04 (Fig 4B). As with capsaicin, MED17.11 cells were not depo-
larised by KCl in proliferating conditions (Fig 4B).
DRG neurons express purinergic receptors and are activated by their endogenous ligand
ATP [27]. 50% of MED17.11 cells responded to ATP (10 μM) (Fig 4B) with a mean response
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amplitude of ΔF/F0: 0.3 ± 0.05 (Fig 4B). Again, we did not observe responses to ATP in control
cells cultured in proliferating conditions.
We next examined the cells for sensitivity to the sodium channel agonist veratridine. This
alkaloid neurotoxin elicits calcium transients in primary adult DRG neurons [28] and preferen-
tially activates TTX sensitive sodium channels by preventing the closure of the inactivation
gate on open sodium channels [29]. Similar to the percentage of cells activated by capsaicin,
75% of MED17.11 cells responded to the compound with a sustained elevation in [Ca2+]i (Fig
4A and 4B), with a mean response amplitude of ΔF/F0: 0.23 ± 0.03. Similarly to other com-
pounds, we did not detect veratridine responses in MED17.11 cells maintained in proliferating
conditions.
TrkA positive neurons give rise to innocuous thermoreceptors and noxious cold sensors.
We looked for functional responses to 30 μMWS-12, a selective compound for the cold recep-
tor TRPM8, whose expression has been reported in embryonic DRG from E16.5 onwards ini-
tially in a subpopulation of TRPV1-positive neurons [9]. We did not observe any calcium
elevation in response to this drug suggesting the cells do not express functional TRPM8 (data
not shown). TRPA1 is an irritant receptor that is predominantly expressed in a subpopulation
Fig 4. Differentiated MED17.11 responds to compounds that excite sensory neurons and
inflammatory mediators. A, representative traces from fura-2 AM calcium imaging showing responses to
compounds that excite DRG neurons following 3–6 days of differentiation. Dotted Lines indicate the time
when the stimulus was applied. B, left, percentage of proliferative and differentiated cells responding to each
compound (Fisher’s Exact two tailed test), * = p<0.05, ** = p<0.001, ***p<0.0001. Right, response
amplitudes to each compound (mean + S.E.M). C, Percentage of MED cells responding when grown in non-
permissive conditions with growth factors alone (NGF 100 ng/ml and GDNF 20 ng/ml) for 3 days. D,
representative traces from fura-2 AM calcium imaging showing responses to inflammatory mediators
following 3–6 days of differentiation. Dotted Lines indicate the time when the stimulus was applied. E, left,
percentage of cells responding to each compound; right, response amplitudes to each compound (mean + S.
E.M).
doi:10.1371/journal.pone.0128670.g004
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of TRPV1 positive neurons [30]. Again we failed to observe responses to the TRPA1 agonist
cinnamaldehyde (200 μM; data not shown).
To validate the effectiveness of our differentiation medium, we cultured MED17.11 cells for
3 days in non-permissive conditions (at 37°C and without IFNγ) with NGF and GDNF but
without bFGF, cAMP, forskolin and Y-27632 (Fig 4C). We did not observe any responses to
KCl or veratridine and only 8% of cells responded to capsaicin (compared to 71% in differenti-
ation medium), thus validating the effectiveness of our differentiation medium.
MED17.11 expresses receptors for inflammatory mediators
Inflammatory mediators released during tissue damage can directly activate nociceptors or sen-
sitise them to subsequent stimuli leading to hyperalgesia [1]. To determine whether differenti-
ated MED17.11 cells have the potential to be used as an in vitromodel to study mechanisms of
peripheral sensitisation, we examined their responses to several inflammatory mediators using
calcium microfluorimetry. Representative traces are shown in Fig 4D. We observed responses
to bradykinin (2 μM), histamine (10 μM) and norepinephrine (10 μM) but we did not observe
any responses to serotonin (10 μM; data not shown).
Bradykinin elicited large calcium transients in 67.2% of cells with a response amplitude ΔF/
F0: 0.39 ± 0.04; (Fig 4E). Interestingly, only 32.7% of MED17.11 cells responded to histamine
(mean response magnitude ΔF/F0: 0.23 ± 0.02). Likewise, only 29.4% of cells responded to nor-
epinephrine with a response magnitude of ΔF/F0: 0.22 ± 0.02 (Fig 4E).
Discussion
We have derived a mouse embryonic DRG cell line, MED17.11, from the Immortomouse. The
expression profile of this cell line correlates best with committed sensory neuron progenitors,
and can be differentiated efficiently to have cytochemical and pharmacological properties con-
sistent with nociceptor-lineage neurons. The cells also expressed markers of mechanoreceptor/
proprioceptor lineage neurons, suggesting that MED17.11 were isolated from DRG committed
cells with multimodal potential.
Differentiated MED17.11 cells are a robust and rapid model for neurite
outgrowth
The rapid and efficient induction of neurogenesis on a simple substrate of polyornithine, fol-
lowing differentiation (Fig 2), together with their transfectibility, could make MED17.11 a par-
ticularly useful model system for the growing field of high content analysis, which combines
automated microscopy with automated analysis for chemical/genetic screens. Quantitation of
neurite outgrowth is the most popular phenotypic screen for neuronal cells. Neuronal-like cell
lines are used as popular model for in vivo neurons in such screens. However, speed and effi-
ciency of differentiation is a specific bottleneck. Within hours of application of our differentia-
tion medium, MED17.11 cells elaborate long processes that extend over time in culture.
Moreover, unlike many widely used cell lines, such as PC-12, MED17.11 does not have a ten-
dency to aggregate in our differentiation conditions (Fig 2B and 2C), which is a distinct advan-
tage for high content screens.
MED17.11 cells have multimodal potential
Using our differentiation protocol, MED17.11 cells rapidly acquire properties of peptidergic
and non-peptidergic nociceptors (Fig 3). Here, we have focused on probing their nociceptive
phenotype, however TrkC and Runx3 expression indicates that they may also still have the
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ability to differentiate into low threshold mechanoreceptors/proprioceptive lineage neurons
[31]. The differentiation medium contains the neurotrophic factors NGF and GDNF, which
are involved in the specification of these populations [32]. We believe that a more defined me-
dium could direct these cells to a specific phenotype. Regardless, this multipotentiality may be
useful to study the mechanisms underlying DRG subpopulation specification. Further studies
in serum-free conditions and perhaps using additional growth factors such as NT3 and BDNF
are needed to determine the degree to which these cells can be directed towards a specific
phenotype.
MED17.11 cells have unique phenotypes
Several other DRG cell lines exist but more are needed to better represent the full complement
of phenotypes observed in the highly heterogeneous DRG. Recently, Vetter et al [33] character-
ised the endogenous calcium responses of various cell lines to compounds known to excite
DRG neurons, including the rat embryonic [2] and neonatal [3] DRG/ mouse neuroblastoma
fusion cell lines, F11 and ND7/23, as well as the T-antigen immortalised rat embryonic 50b11
cell line [4]. They used several compounds also tested here: bradykinin, histamine, ATP and
capsaicin. Comparison with their results suggests that MED cells have unique properties. For
instance, like MED17.11, F11 and 50b11 responded to ATP whereas ND7/23 cells were insensi-
tive. Vetter et al did not detect responses to capsaicin in any of these cell lines, however, this
contrasts previous reports for 50b11 [4]. The reasons for this are unclear, but could be related
to differences in experimental parameters [33]. F11 cells lose their capsaicin sensitivity over
time in culture [34], with genetic loss being a characteristic drawback of somatic cell fusion
lines. Unlike MED17.11, none of these cell lines responded to histamine. F11 and ND7/23, but
not 50b11 cells responded to bradykinin, with F11 showing particularly large calcium tran-
sients. MED17.11 was sensitive to bradykinin. Similarly, this is the first report of endogenous
Piezo 2 expression in a DRG cell line, so it will be interesting to evaluate the mechanoreceptive
properties of MED17.11 cells.
We did not detect expression of Nav1.8 using mRNA analysis. This channel is first detected
at E15 in rat DRG [26], however, the onset of expression is differentially regulated within DRG
subpopulations. MED17.11 strongly labelled with IB4 and in this population, Nav1.8 first ap-
pears only after Nav1.9 expression in the late embryonic period [26]. Immunoreactivity with
NaV1.3 suggests that MED17.11 in our differentiation conditions for 7 days still have an em-
bryonic phenotype. It is possible that culturing MED17.11 for longer periods could lead to the
expression of Nav1.8 or that our culture conditions lacked an essential factor governing its ex-
pression. However, the mechanisms underlying induction of expression of Nav1.8 during de-
velopment are unknown. We also failed to observe functional responses to the TRPA1 agonist
cinnamaldehyde. Again, it is possible that the time-point chosen could be too early to detect
this marker as the onset of functional TRPA1 expression occurs in the post-embryonic period
(from P0 in peptidergic nociceptors and P14 in non-peptidergic nociceptors; (9)).
A differentiation medium for rapid and efficient cytochemical
differentiation
Using our differentiation medium, MED17.11 cells cultured on polyornithine rapidly acquired
markers of post-mitotic sensory neurons and differentiated morphologically with high efficien-
cy. Neural crest cell specification of DRG neurons is an active area of study. Recently, great
strides have been made in this area to produce sensory neurons from human pluripotent stem
cells (hPSCs) using combined small molecule inhibition [5,6]. After 10 days these cells begin to
express early markers of sensory neurons, including Brn3a and Isl1, similar to the expression
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profile of non-differentiated MED17.11. These cells are then grown in basic medium supple-
mented with growth factors and ascorbic acid and subsequently acquire nociceptor transcrip-
tion factors and functional ion channel expression after a further 2–6 weeks in culture. This is
in strong contrast to differentiated MED17.11 cells where we detected nociceptive markers
after 1–7 days. Notably, the acquisition of the important nociceptor transcription factor,
Runx1 was not detected in hPSCs-derived neurons until 4 weeks of culture in growth factors.
In addition, veratridine and ATP sensitivity was not observed until 2 weeks post-differentiation
in response to growth factors. Capsaicin responses were only seen after 6 weeks and in just
1–2% of cells. This is in contrast to MED17.11 cells which respond to both ATP (50%) and cap-
saicin (71%) after just a few days of differentiation. Indeed when we cultured MED17.11 in just
NGF and GDNF, we observed little functional differentiation (Fig 4D) compared with using
our primary differentiation medium (Fig 4B). Therefore it will be interesting to determine
whether our differentiation medium can be applied to neuralised hPSCs to accelerate acquisi-
tion of sensory neuron markers. The time saved (days instead of weeks) will have a significant
impact on the suitability of MED17.11 or hPSCs derived neurons for high-throughput drug
screens. Moreover, immortalising differentiated hPSCs at the same developmental stage as
MED cell lines might further simplify the derivation of sensory neurons from hPSCs by elimi-
nating the need to maintain and manipulate stem cells. Recently, Wainger et al derived noci-
ceptors from fibroblasts by transfecting them with five transcription factors. Moreover, the
fibroblasts were derived from patients with familial dysautonomia [35], thus providing a novel
way to model human neuronal disease in vitro. This is an extremely encouraging development
for the field. But for many basic researchers, a simpler, cheaper and quicker method for deriv-
ing sensory neurones in culture is necessary and thus MED17.11 cells may be more suitable for
this work.
In summary, MED17.11 cells have the capability of differentiating into sensory neurons of
multiple modalities, with particularly strong evidence that they differentiate efficiently into no-
ciceptive-lineage neurons. Moreover, like primary DRG neurons they are sensitive to inflam-
matory mediators. The advantage of creating a temperature-dependent conditional cell line
means that there is a continuous supply of material, but that any confounding effects that the
immortalising gene on phenotype can be reduced. MED17.11 cells can be induced to undergo
rapid and efficient maturation into sensory neurons using our differentiation medium; en-
abling large scale preparations for high-throughput and “omic” screens. The use of MED17.11
should aid basic and pharmaceutical research by providing an in vitromodel to study the mo-
lecular mechanisms underlying nociception, neuronal development and phenotype specifica-
tion, while at the same time reducing the number of animals used to derive primary cultures.
Author Contributions
Conceived and designed the experiments: MAN CD. Performed the experiments: CD JC
MAN. Analyzed the data: CD JC MCH DGMAN. Contributed reagents/materials/analysis
tools: DG. Wrote the paper: CD MAN. Contributed to the writing of the grant proposal, man-
agement of the project and commented on the manuscript: MCH DG.
References
1. Dray A (1995) Inflammatory mediators of pain. Br J Anaesth 75: 125–131. PMID: 7577246
2. Platika D, Boulos MH, Baizer L, Fishman MC (1985) Neuronal traits of clonal cell lines derived by fusion
of dorsal root ganglia neurons with neuroblastoma cells. Proc Natl Acad Sci U S A 82: 3499–3503.
PMID: 3858835
Immortalized DRG Cell Line
PLOS ONE | DOI:10.1371/journal.pone.0128670 June 8, 2015 13 / 15
3. Wood JN, Bevan SJ, Coote PR, Dunn PM, Harmar A, et al. (1990) Novel Cell Lines Display Properties
of Nociceptive Sensory Neurons. Proceedings of the Royal Society of London Series B: Biological Sci-
ences 241: 187–194. PMID: 1979443
4. ChenW, Mi R, Haughey N, Oz M, Hoke A (2007) Immortalization and characterization of a nociceptive
dorsal root ganglion sensory neuronal line. J Peripher Nerv Syst 12: 121–130. PMID: 17565537
5. Young GT, Gutteridge A, Fox HDE, Wilbrey AL, Cao L, et al. (2014) Characterizing Human Stem Cell-
derived Sensory Neurons at the Single-cell Level Reveals Their Ion Channel Expression and Utility in
Pain Research. Mol Ther 22: 1530–1543. doi: 10.1038/mt.2014.86 PMID: 24832007
6. Chambers SM, Qi Y, Mica Y, Lee G, Zhang XJ, et al. (2012) Combined small-molecule inhibition accel-
erates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotech-
nol 30: 715–720. doi: 10.1038/nbt.2249 PMID: 22750882
7. Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, et al. (1991) Direct derivation of conditionally
immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proceedings of the National Academy of
Sciences 88: 5096–5100. PMID: 1711218
8. Baker MD, Bostock H (1997) Low-threshold, persistent sodium current in rat large dorsal root ganglion
neurons in culture. J Neurophysiol 77: 1503–1513. PMID: 9084615
9. Hjerling-Leffler J, AlQatari M, Ernfors P, Koltzenburg M (2007) Emergence of Functional Sensory Sub-
types as Defined by Transient Receptor Potential Channel Expression. The Journal of Neuroscience
27: 2435–2443. PMID: 17344381
10. Sun Y, Dykes IM, Liang X, Eng SR, Evans SM, et al. (2008) A central role for Islet1 in sensory neuron
development linking sensory and spinal gene regulatory programs. Nat Neurosci 11: 1283–1293. doi:
10.1038/nn.2209 PMID: 18849985
11. Virginie Neirinckx CcC, Bernard Rogister,SabineWislet- Gendebien (2013) Neural Fate of Mesenchy-
mal Stem Cells and Neural Crest Stem Cells: WhichWays to Get Neurons for Cell Therapy Purpose?
Trends in Cell Signaling Pathways in Neuronal Fate Decision.
12. Fournier AE, Takizawa BT, Strittmatter SM (2003) Rho kinase inhibition enhances axonal regeneration
in the injured CNS. J Neurosci 23: 1416–1423. PMID: 12598630
13. Neirinckx V, Coste C, Rogister B, Wislet-Gendebien S (2013) Concise review: adult mesenchymal
stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem
Cells Transl Med 2: 284–296. doi: 10.5966/sctm.2012-0147 PMID: 23486833
14. Matsuda S, Uehara Y (1984) Prenatal development of the rat dorsal root ganglia. Cell and Tissue Re-
search 235: 13–18. PMID: 6697377
15. Montelius A, Marmigère F, Baudet C, Aquino JB, Enerbäck S, et al. (2007) Emergence of the sensory
nervous system as defined by Foxs1 expression. Differentiation 75: 404–417. PMID: 17309606
16. Ravenall SJ, Gavazzi I, Wood JN, Akopian AN (2002) A peripheral nervous system actin-binding pro-
tein regulates neurite outgrowth. European Journal of Neuroscience 15: 281–290. PMID: 11849295
17. Minett MS, Nassar MA, Clark AK, Passmore G, Dickenson AH, et al. (2012) Distinct Nav1.7-dependent
pain sensations require different sets of sensory and sympathetic neurons. Nat Commun 3: 791. doi:
10.1038/ncomms1795 PMID: 22531176
18. Kim J, Lo L, Dormand E, Anderson DJ (2003) SOX10Maintains Multipotency and Inhibits Neuronal Dif-
ferentiation of Neural Crest Stem Cells. Neuron 38: 17–31. PMID: 12691661
19. Chen C-L, Broom DC, Liu Y, de Nooij JC, Li Z, et al. (2006) Runx1 Determines Nociceptive Sensory
Neuron Phenotype and Is Required for Thermal and Neuropathic Pain. Neuron 49: 365–377. PMID:
16446141
20. Shibasaki K, Murayama N, Ono K, Ishizaki Y, Tominaga M (2010) TRPV2 Enhances Axon Outgrowth
through Its Activation by Membrane Stretch in Developing Sensory and Motor Neurons. The Journal of
Neuroscience 30: 4601–4612. doi: 10.1523/JNEUROSCI.5830-09.2010 PMID: 20357111
21. Coste B, Mathur J, Schmidt M, Earley TJ, Ranade S, et al. (2010) Piezo1 and Piezo2 are essential com-
ponents of distinct mechanically activated cation channels. Science 330: 55–60. doi: 10.1126/science.
1193270 PMID: 20813920
22. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, et al. (2006) An SCN9A channelopathy
causes congenital inability to experience pain. Nature 444: 894–898. PMID: 17167479
23. Nassar MA, Stirling LC, Forlani G, Baker MD, Matthews EA, et al. (2004) Nociceptor-specific gene dele-
tion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A
101: 12706–12711. PMID: 15314237
24. Fang X, Djouhri L, McMullan S, Berry C, Waxman SG, et al. (2006) Intense isolectin-B4 binding in rat
dorsal root ganglion neurons distinguishes C-fiber nociceptors with broad action potentials and high
Nav1.9 expression. J Neurosci 26: 7281–7292. PMID: 16822986
Immortalized DRG Cell Line
PLOS ONE | DOI:10.1371/journal.pone.0128670 June 8, 2015 14 / 15
25. Fjell J, Cummins TR, Dib-Hajj SD, Fried K, Black JA, et al. (1999) Differential role of GDNF and NGF in
the maintenance of two TTX-resistant sodium channels in adult DRG neurons. Brain Res Mol Brain
Res 67: 267–282. PMID: 10216225
26. Benn SC, Costigan M, Tate S, Fitzgerald M, Woolf CJ (2001) Developmental expression of the TTX-re-
sistant voltage-gated sodium channels Nav1.8 (SNS) and Nav1.9 (SNS2) in primary sensory neurons.
J Neurosci 21: 6077–6085. PMID: 11487631
27. Ueno S, Tsuda M, Iwanaga T, Inoue K (1999) Cell type-specific ATP-activated responses in rat dorsal
root ganglion neurons. Br J Pharmacol 126: 429–436. PMID: 10077235
28. Teichert RW, Raghuraman S, Memon T, Cox JL, Foulkes T, et al. (2012) Characterization of two neuro-
nal subclasses through constellation pharmacology. Proc Natl Acad Sci U S A 109: 12758–12763. doi:
10.1073/pnas.1209759109 PMID: 22778416
29. Barnes S, Hille B (1988) Veratridine modifies open sodium channels. J Gen Physiol 91: 421–443.
PMID: 2454286
30. Kobayashi K, Fukuoka T, Obata K, Yamanaka H, Dai Y, et al. (2005) Distinct expression of TRPM8,
TRPA1, and TRPV1mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with
trk receptors. J Comp Neurol 493: 596–606. PMID: 16304633
31. Marmigere F, Ernfors P (2007) Specification and connectivity of neuronal subtypes in the sensory line-
age. Nat Rev Neurosci 8: 114–127. PMID: 17237804
32. Molliver DC, Snider WD (1997) Nerve growth factor receptor trkA is down-regulated during postnatal
development by a subset of dorsal root ganglion neurons. The Journal of Comparative Neurology 381:
428–438. PMID: 9136800
33. Vetter I, Lewis RJ (2010) Characterization of endogenous calcium responses in neuronal cell lines. Bio-
chemical Pharmacology 79: 908–920. doi: 10.1016/j.bcp.2009.10.020 PMID: 19883631
34. Kusano K, Gainer H (1993) Modulation of voltage-activated Ca currents by pain-inducing agents in a
dorsal root ganglion neuronal line, F-11. Journal of Neuroscience Research 34: 158–169. PMID:
8383774
35. Wainger BJ, Buttermore ED, Oliveira JT, Mellin C, Lee S, et al. (2015) Modeling pain in vitro using noci-
ceptor neurons reprogrammed from fibroblasts. Nat Neurosci 18: 17–24. doi: 10.1038/nn.3886 PMID:
25420066
Immortalized DRG Cell Line
PLOS ONE | DOI:10.1371/journal.pone.0128670 June 8, 2015 15 / 15
